PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-0.03
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
1.13
P/S 50-75% of CRN.AX's 1.51. Bruce Berkowitz would examine if sales quality justifies the gap.
-0.16
Negative equity while CRN.AX shows P/B of 0.74. Joel Greenblatt would examine balance sheet repair potential.
-0.71
Negative FCF while CRN.AX shows P/FCF of 50.98. Joel Greenblatt would examine cash flow improvement potential.
-4.55
Negative operating cash flow while CRN.AX shows P/OCF of 12.69. Joel Greenblatt would examine operational improvement potential.
-0.16
Negative fair value while CRN.AX shows ratio of 0.74. Joel Greenblatt would examine valuation model differences.
-960.00%
Both companies show losses. Martin Whitman would check for industry-wide issues.
-140.51%
Negative FCF while CRN.AX shows yield of 1.96%. Joel Greenblatt would examine cash flow improvement potential.